vs
Side-by-side financial comparison of Dine Brands Global, Inc. (DIN) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $217.6M, roughly 1.4× Dine Brands Global, Inc.). Bio-Techne runs the higher net margin — 12.8% vs -5.6%, a 18.5% gap on every dollar of revenue. On growth, Dine Brands Global, Inc. posted the faster year-over-year revenue change (6.3% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 2.7%).
Dine Brands Global Inc. is a publicly traded food and beverage company based in Pasadena, California. Founded in 1958 as IHOP, it operates franchised and corporate owned full-service restaurants including three restaurant concepts, Applebee's Neighborhood Grill & Bar, International House of Pancakes (IHOP), and Fuzzy's Taco Shop.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DIN vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $217.6M | $295.9M |
| Net Profit | $-12.2M | $38.0M |
| Gross Margin | 42.4% | 64.6% |
| Operating Margin | -7.6% | 18.4% |
| Net Margin | -5.6% | 12.8% |
| Revenue YoY | 6.3% | -6.4% |
| Net Profit YoY | -336.1% | 68.3% |
| EPS (diluted) | $-0.79 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $217.6M | $295.9M | ||
| Q3 25 | $216.2M | — | ||
| Q2 25 | $230.8M | $317.0M | ||
| Q1 25 | $214.8M | $316.2M | ||
| Q4 24 | $204.8M | $297.0M | ||
| Q3 24 | $195.0M | $289.5M | ||
| Q2 24 | $206.3M | $306.1M | ||
| Q1 24 | $206.2M | $303.4M |
| Q4 25 | $-12.2M | $38.0M | ||
| Q3 25 | $7.3M | — | ||
| Q2 25 | $13.8M | $-17.7M | ||
| Q1 25 | $8.2M | $22.6M | ||
| Q4 24 | $5.2M | $34.9M | ||
| Q3 24 | $19.1M | $33.6M | ||
| Q2 24 | $23.2M | $40.6M | ||
| Q1 24 | $17.5M | $49.1M |
| Q4 25 | 42.4% | 64.6% | ||
| Q3 25 | 39.1% | — | ||
| Q2 25 | 40.0% | 62.7% | ||
| Q1 25 | 42.0% | 67.9% | ||
| Q4 24 | 41.7% | 65.3% | ||
| Q3 24 | 47.8% | 63.2% | ||
| Q2 24 | 48.1% | 66.4% | ||
| Q1 24 | 47.2% | 67.4% |
| Q4 25 | -7.6% | 18.4% | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 8.2% | -7.5% | ||
| Q1 25 | 6.0% | 12.2% | ||
| Q4 24 | 3.8% | 16.0% | ||
| Q3 24 | 13.6% | 13.8% | ||
| Q2 24 | 15.1% | 15.0% | ||
| Q1 24 | 11.7% | 22.1% |
| Q4 25 | -5.6% | 12.8% | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 6.0% | -5.6% | ||
| Q1 25 | 3.8% | 7.1% | ||
| Q4 24 | 2.5% | 11.7% | ||
| Q3 24 | 9.8% | 11.6% | ||
| Q2 24 | 11.2% | 13.3% | ||
| Q1 24 | 8.5% | 16.2% |
| Q4 25 | $-0.79 | $0.24 | ||
| Q3 25 | $0.48 | — | ||
| Q2 25 | $0.89 | $-0.11 | ||
| Q1 25 | $0.53 | $0.14 | ||
| Q4 24 | $0.35 | $0.22 | ||
| Q3 24 | $1.24 | $0.21 | ||
| Q2 24 | $1.50 | $0.26 | ||
| Q1 24 | $1.13 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.2M | $172.9M |
| Total DebtLower is stronger | $1.2B | $260.0M |
| Stockholders' EquityBook value | $-273.9M | $2.0B |
| Total Assets | $1.7B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.2M | $172.9M | ||
| Q3 25 | $167.9M | — | ||
| Q2 25 | $194.2M | $162.2M | ||
| Q1 25 | $186.5M | $140.7M | ||
| Q4 24 | $186.7M | $177.5M | ||
| Q3 24 | $169.6M | $187.5M | ||
| Q2 24 | $153.5M | $152.9M | ||
| Q1 24 | $145.0M | $145.3M |
| Q4 25 | $1.2B | $260.0M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | $346.0M | ||
| Q1 25 | $1.2B | $330.0M | ||
| Q4 24 | $1.2B | $300.0M | ||
| Q3 24 | $1.2B | $300.0M | ||
| Q2 24 | $1.2B | $319.0M | ||
| Q1 24 | $1.2B | $389.0M |
| Q4 25 | $-273.9M | $2.0B | ||
| Q3 25 | $-231.9M | — | ||
| Q2 25 | $-212.5M | $1.9B | ||
| Q1 25 | $-215.7M | $2.0B | ||
| Q4 24 | $-216.0M | $2.1B | ||
| Q3 24 | $-216.7M | $2.1B | ||
| Q2 24 | $-231.7M | $2.1B | ||
| Q1 24 | $-244.8M | $2.0B |
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.8B | $2.6B | ||
| Q4 24 | $1.8B | $2.7B | ||
| Q3 24 | $1.7B | $2.7B | ||
| Q2 24 | $1.7B | $2.7B | ||
| Q1 24 | $1.7B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.7M | — |
| Free Cash FlowOCF − Capex | $-8.6M | — |
| FCF MarginFCF / Revenue | -3.9% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $53.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.7M | — | ||
| Q3 25 | $30.2M | — | ||
| Q2 25 | $37.0M | $98.2M | ||
| Q1 25 | $16.1M | $41.1M | ||
| Q4 24 | $30.5M | $84.3M | ||
| Q3 24 | $25.5M | $63.9M | ||
| Q2 24 | $21.6M | $75.5M | ||
| Q1 24 | $30.6M | $81.0M |
| Q4 25 | $-8.6M | — | ||
| Q3 25 | $18.1M | — | ||
| Q2 25 | $31.0M | $93.3M | ||
| Q1 25 | $12.8M | $31.0M | ||
| Q4 24 | $26.7M | $77.5M | ||
| Q3 24 | $22.0M | $54.7M | ||
| Q2 24 | $18.2M | $57.5M | ||
| Q1 24 | $27.2M | $64.5M |
| Q4 25 | -3.9% | — | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | 13.4% | 29.4% | ||
| Q1 25 | 6.0% | 9.8% | ||
| Q4 24 | 13.0% | 26.1% | ||
| Q3 24 | 11.3% | 18.9% | ||
| Q2 24 | 8.8% | 18.8% | ||
| Q1 24 | 13.2% | 21.3% |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 2.6% | 1.5% | ||
| Q1 25 | 1.5% | 3.2% | ||
| Q4 24 | 1.9% | 2.3% | ||
| Q3 24 | 1.8% | 3.2% | ||
| Q2 24 | 1.7% | 5.9% | ||
| Q1 24 | 1.6% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 4.12× | — | ||
| Q2 25 | 2.68× | — | ||
| Q1 25 | 1.97× | 1.82× | ||
| Q4 24 | 5.88× | 2.42× | ||
| Q3 24 | 1.34× | 1.90× | ||
| Q2 24 | 0.93× | 1.86× | ||
| Q1 24 | 1.75× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIN
| Franchisor | $163.2M | 75% |
| Food And Beverage | $27.3M | 13% |
| Proprietary Product Sales And Other | $17.0M | 8% |
| Other | $8.1M | 4% |
| Franchise And Development Fees | $2.0M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
